Abstract
RAMIS was an observational, retrospective, single-arm study, based on medical record review of patients with advanced gastric cancer (AGC) or gastro-esophageal junction (GEJ) adenocarcinoma treated with ramucirumab in real clinical practice. The observational study period was from December 2015 to December 2018. A total of 20 Spanish hospitals participated in the study, collecting data from 317 patients (297 treated with ramucirumab with paclitaxel and 20 patients treated with ramucirumab as monotherapy).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Annals of oncology : official journal of the European Society for Medical Oncology
Paper Title
Journal
Date
